Stijn Kneefel

In 2025, I obtained my master’s degree in Biomolecular Science at the Vrije Universiteit (VU) Amsterdam. During my master, I did an internship in the group of Dr. Sandra van Vliet at the MCBI, Amsterdam UMC, with Dr. Rémi Hatinguais, about tumour glycosylation affecting the immune system. I also did an internship in the group of Dr. Monika Wolkers at Sanquin with Dr. Kaspar Bresser, about regulators of dysfunctional phenotype acquisition by T cells.

In October 2025, I joined the group of Heinz Jacobs as a PhD student. My project focuses on the cellular and molecular mechanisms behind the synergy of epigenomic-epigenomic and epigenomic-metabolomic drug combination.